KMDA

Kamada (KMDA)

About Kamada (KMDA)

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Details

Daily high

$7.22

Daily low

$7.06

Price at open

$7.18

52 Week High

$8.90

52 Week Low

$5.52

Market cap

410.7M

Dividend yield

0.00%

Volume

34,265

Avg. volume

99,737

P/E ratio

20.05

Kamada News